Idexx Laboratories IDXX Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

DanaherDHR

$1.3B+8.3%

Bio-Rad LaboratoriesBIO

$174.8M+4.3%

Agilent TechnologiesA

$187M-1.1%

VeracyteVCYT

$39.33M-22.1%

WAT

Waters CorporationWAT

$355M—

Insight Molecular Diagnostics Inc.IMDX

$1.97M-18.2%

FAQ

What is Idexx Laboratories's operating lease liabilities (total)?

Idexx Laboratories (IDXX) reported operating lease liabilities (total) of $125.6M in Q1 2026.

How has Idexx Laboratories's operating lease liabilities (total) changed year-over-year?

Idexx Laboratories's operating lease liabilities (total) increased by 5.4% year-over-year, from $119.13M to $125.6M.

What is the long-term trend for Idexx Laboratories's operating lease liabilities (total)?

Over 5 years (2020 to 2025), Idexx Laboratories's operating lease liabilities (total) has grown at a 6.2% compound annual growth rate (CAGR), from $94.77M to $128.23M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.